Opportunities for Drug Repurposing of Serotonin Reuptake Inhibitors: Potential Uses in Inflammation, Infection, Cancer, Neuroprotection, and Alzheimer’s Disease Prevention is a research paper published in Pharmacopsychiatry (2021). On theSindex it has a DataRank of 0. It has been cited 30 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health grant
Grant: NIH R25 MH112473-01
NIH R25 MH112473-01
Grant: National Institutes of Health grant
PCORI and COVID Early Treatment Fund Emergent Ventures FastGrants
EJL and AMR are inventors on a patent application related to COVID- 19 research including sigma-1 receptor agonists
CFZ is on the scientific advisory board and receives stock options from Sage Therapeutics
EJL is a consultant for Prodeo
MeSH Terms